At the University for Kentucky, understanding and addressing the health needs of the people of the Commonwealth is the goal of many faculty, staff, clinicians and researchers. As a step toward improving health equity, the University of Kentucky Center for Health Equity Transformation (CHET) was established and recently approved by the UK Board of Trustees. 

Ten researchers from institutions across the U.S. have been selected to participate in the American Society for Biochemistry and Molecular Biology (ASBMB) Advocacy Training Program, a rigorous six-month program aiming to produce the next generation of science advocates. Among those chosen is Aria Byrd, a doctoral candidate in the University of Kentucky College of Medicine and researcher in the Fillmore Brainson Lab. 

According to the Blue Ridge Institute for Medical Research (http://www.brimr.org/default.htm), with just under $11,000,000 in NIH research funding, the Department of Molecular & Cellular Biochemistry is ranked 19th among biochemistry departments in medical schools in the United States.

We are now offering a single domain antibody (Nanobody®) production service. Nanobodies, in contrast to conventional antibodies which are made up of two heavy and two light chains with a molecular weight of ~150,000, are composed of only heavy chains. The heavy chain nanobody domains can be isolated as a small 15,000 Da single domain antibody, which retains the high affinity of conventional antibodies. Due to their small size nanobodies can be expressed in E. coli and their cDNAs manipulated in a variety of ways.

Founded in 1912, The Federation of American Societies for Experimental Biology (FASEB) was originally created by three independent scientific organizations to provide a forum in which to hold educational meetings, develop publications, and disseminate biological research results. The association has grown to be the nation’s largest coalition of biomedical researchers, representing 30 societies and over 130,000 researchers from around the world. FASEB is now recognized as the policy voice of biological and biomedical researchers. Dr.

The University of Kentucky Department of Otolaryngology-Head & Neck Surgery celebrated the graduation of Kristan Alfonso, MD, Caitlin Fiorillo, MD, and Mitch Dobberpuhl, MD the weekend of June 15-16, 2018.  A formal dinner was held at Malone’s Friday evening to celebrate the accomplishments of the graduates, followed by an informal picnic attended by over 100 members and families of UK Healthcare.  Dr.

The University of Kentucky Department of Otolaryngology-Head & Neck Surgery hosted the 4th Annual Bluegrass Research Symposium at the Hillary Boone Center on the campus of the University of Kentucky on May 4, 2018.  The symposium highlighted the exceptional high-impact research conducted in the department led by current residents. This event brought together UK faculty, residents, students and Otolaryngologists across the Commonwealth. Drs. Nicole Craker and Kyle Fletcher were awarded the residency research awards for outstanding presentations.

The University of Kentucky Department of Otolaryngology-Head & Neck Surgery was well represented at the 2018 Kentucky Society of Otolaryngology Annual Meeting May 18-19, 2018, at the Muhammed Ali Center in Louisville, Kentucky.  Kyle Fletcher, MD, PharmD was a resident research award winner and presented “Comparison In-Person versus Telemedicine Cochlear Implant Evaluations: A Pilot Study.”   Brett Comer, MD, presented on “Packing Materials after FESS: What is the Current Evidence?”  Beth McNulty, MD, served as proctor for the resident quiz bowl.